🇪🇺 Aranesp in European Union

Aranesp (DARBEPOETIN ALFA) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000332
  • Local brand name: Aranesp
  • Status: approved

Aranesp in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in European Union

Frequently asked questions

Is Aranesp approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Aranesp in European Union?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.